trending Market Intelligence /marketintelligence/en/news-insights/trending/R0LVh4QhTml3BYXhXZhFGQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Synlogic names COO

COVID-19 Impact & Recovery: Corporations

Blog

COVID-19 Impact & Recovery: Commercial Real estate

Blog

One Year After the COVID Crash: Assessing the Leveraged Loan Market

Blog

COVID-19 Impact & Recovery: Investment Banking


Synlogic names COO

Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.

Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.